The Department of Endocrinology, Morbid Obesity and Preventive Medicine (ESF) performs research in diabetes, metabolism, inherited and acquired lipid diseases, thyroid function, bone and calcium diseases, gonadal, pituitary and adrenal diseases, overweight and obesity and related conditions. We participate in research after whole organ and islet cell transplantation and in hormonal treatment for gender incongruence. We have decades of experience with self-initiated research, linked to a close collaboration with a number of clinical OUH Departments, the Hormone Laboratory, radiology units, the University of Oslo and other external partners.

Aims:

Maintain high quality and output of publications and participation in contract and self-initiated studies.

We treat chronic conditions, so we aim to explore pathophysiology and improve treatment through clinical studies as well as translational projects, where maintenance and expansion of disease related registries and biobanks are of great importance, - especially for projects in –omics, genetics and epigenetics. We will continue to work with existing national and international partners and prioritize researcher mobility and establishment of new collaborations.

Chronic conditions have challenges meeting treatment goals, especially in high risk groups. Hence our research must also address benchmarking, communication and compliance, health literacy and minority issues. Furthermore we aim to increase research contributions in nursing sciences, innovation and on quality of life and continue to implement user participation in our research. 

Research strategy

• The Lipid Clinic (Asprusten)
• Diabetes type 1 - Diabetes 1 (Julsrud Berg)
• Type 2 diabetes and metabolism (Birkeland)
• Specialized endocrinology (Bollerslev)
• Morbid Obesity Research Group (Mala)
• Preventive Cardiology (Sveen)
• Thyroid and Osteoporosis Research group (Hammerstad)